The latest release of Sophia AI merges imaging analysis with genomic medicine in pursuit of better diagnosis and treatment.
The partnership will integrate Ambry Genetics' and Invicro's technologies to expedite new drug discovery and development.
A University of Oxford-led team combined imaging and genotyping data to find variants that affect how a person's facial profile or eyes look.
The partners will integrate genomic, imaging, and other data to identify new therapies and personalize treatments for patients with neurological and neurodegenerative diseases.
At the European Society of Human Genetics annual meeting in Copenhagen this week, several groups presented studies involving automated facial analysis software.
FDNA's Face2Gene suite analyzes phenotypic data, including facial features, from rare disease patients.
The firm's first assay will be for Hodgkin lymphoma, but a liquid biopsy test for prostate cancer has also shown strong predictive power in initial validation data.
The new institute plans to use structured clinical information to inform targeted testing in order to cut down the time to diagnosis.
The company said the divestiture to Varian Medical Systems would allow it to concentrate on investing in high-growth parts of its business.
In Science this week: imaging approach to visual epigenetic activity in the brain, and more.
A new study in JAMA finds that genetic tests might not be able to determine what diet is right for someone seeking to lose weight.
A genome-wide association study that linked common genetic variants to salivary gland carcinoma risk has been retracted, according to Retraction Watch.
Vampire bats' ability to live off blood is etched in their genomes and gut microbiomes, the Scientist reports.
In Genome Biology this week: peopling of the Sahara, epigenetic reprogramming analysis of liverwort, and more.